Table 2.
Plasma fibrinolytic markers.
| Group I | Groups II/III | Group IV | P | |
|---|---|---|---|---|
| n | 35 | 31 | 57 | — |
| PAI-1 | 34.90 (27.86; 42.43) | 40.50 (34.24; 51.83) | 66.60a,b(44.70; 91.65) | P < 0.001 |
| TAFI | 5.71 ± 1.73 | 5.21 ± 1.42 | 4.97 ± 1.41 | ns |
n = sample size; Group I = normal; Groups II/III = mild/moderate atheromatosis, up to 70% in at least one coronary artery; Group IV = severe atheromatosis, >70% in at least one coronary artery; PAI-1 = type 1 plasminogen activator inhibitor; TAFI = thrombin activatable fibrinolysis inhibitor; aversus Group I and bversus Groups II/III; ns = not significant.
Values for PAI-1 are given in median (25th and 75th percentiles) and expressed in (ng/mL).
Values for TAFI are given in mean ± SD and expressed in (μg/mL).